These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates. Sánchez A; Blanco R Osteoporos Int; 2017 Mar; 28(3):1145-1147. PubMed ID: 27866217 [TBL] [Abstract][Full Text] [Related]
8. Signs of Insufficiency Fractures Overlooked in a Patient Receiving Chronic Bisphosphonate Therapy. Shaikh W; Morris D; Morris S J Am Board Fam Med; 2016; 29(3):404-7. PubMed ID: 27170798 [TBL] [Abstract][Full Text] [Related]
9. Unusual subtrochanteric femoral insufficiency fractures associated with the prolonged use of alendronate and risedronate: a report of two cases. Angthong C; Angthong W J Med Assoc Thai; 2011 Dec; 94 Suppl 7():S214-20. PubMed ID: 22619933 [TBL] [Abstract][Full Text] [Related]
10. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. Goh SK; Yang KY; Koh JS; Wong MK; Chua SY; Chua DT; Howe TS J Bone Joint Surg Br; 2007 Mar; 89(3):349-53. PubMed ID: 17356148 [TBL] [Abstract][Full Text] [Related]
13. Bilateral atypical femoral fractures after long-term alendronate therapy: a case report. Bamrungsong T; Pongchaiyakul C J Med Assoc Thai; 2010 May; 93(5):620-4. PubMed ID: 20524451 [TBL] [Abstract][Full Text] [Related]
14. [Osteoporotic fracture in menopausal women: alendronate reduces the risk]. Bize R; Lamy O; Peytremann-Bridevaux I Rev Med Suisse; 2008 Dec; 4(183):2703. PubMed ID: 19157286 [No Abstract] [Full Text] [Related]
15. Bisphosphonate-related subtrochanteric femoral fractures. Gunawardena I; Baxter M; Rasekh Y Am J Geriatr Pharmacother; 2011 Jun; 9(3):194-8. PubMed ID: 21470918 [TBL] [Abstract][Full Text] [Related]
16. Case reports: two femoral insufficiency fractures after long-term alendronate therapy. Sayed-Noor AS; Sjödén GO Clin Orthop Relat Res; 2009 Jul; 467(7):1921-6. PubMed ID: 19198962 [TBL] [Abstract][Full Text] [Related]
17. [Treatment with bisphosphonates as a possible cause of bilateral spontaneous atypical femoral fracture]. Rasmussen M; Lange J Ugeskr Laeger; 2012 Jan; 174(1-2):32-3. PubMed ID: 22233718 [TBL] [Abstract][Full Text] [Related]
18. A rational approach to management of alendronate-related subtrochanteric fractures. Das De S; Setiobudi T; Shen L; Das De S J Bone Joint Surg Br; 2010 May; 92(5):679-86. PubMed ID: 20436006 [TBL] [Abstract][Full Text] [Related]
19. Femoral shaft fractures in the elderly--role of prior bisphosphonate therapy. Ng YH; Gino PD; Lingaraj K; Das De S Injury; 2011 Jul; 42(7):702-6. PubMed ID: 21316051 [TBL] [Abstract][Full Text] [Related]
20. A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture. Cross MB; Nam D; van der Meulen MC; Bostrom MP J Bone Joint Surg Br; 2012 Jul; 94(7):994-7. PubMed ID: 22733959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]